Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,686
Total Claims
$844K
Drug Cost
1,311
Beneficiaries
$644
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 109,535 Physician Assistant providers
-97%
Opioid rate vs peers
0.3% vs 9.2% avg
-10%
Cost per patient vs peers
$644 vs $719 avg
+76%
Brand preference vs peers
11.7% vs 6.7% avg
Opioid Prescribing
0.3%
Opioid Rate
28
Opioid Claims
$297
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,236 claims · $673K
Generic: 9,338 claims · $165K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 128 | $115K |
| Dulaglutide | 76 | $96K |
| Dapagliflozin Propanediol | 49 | $43K |
| Empagliflozin | 44 | $42K |
| Rivaroxaban | 42 | $33K |
| Sitagliptin Phosphate | 38 | $30K |
| Insulin Glargine,hum.Rec.Anlog | 17 | $24K |
| Fluticasone/Umeclidin/Vilanter | 23 | $24K |
| Budesonide/Formoterol Fumarate | 40 | $21K |
| Budesonide/Glycopyr/Formoterol | 20 | $14K |
| Tiotropium Bromide | 17 | $13K |
| Semaglutide | 11 | $12K |
| Fluticasone Propion/Salmeterol | 20 | $11K |
| Sacubitril/Valsartan | 22 | $11K |
| Fluticasone/Vilanterol | 23 | $11K |
Prescribing Profile
Patient Profile
70
Avg Age
57%
Female
1.40
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About